healthmate inc said its auditors laventhol and horwath indicated will issue qualified opinion company financial statements company which went public march 1985 earlier reported losses for fourth quarter said auditor statement known subject opinion cautions because continuing operating losses and negative cash flow must achieve profitable operations acquire additional equity capital financing continue existence healthmate reported loss for year 512 534 dlrs cts share revenues mln dlrs year ago had loss 553 592 dlrs cts share revenues 515 225 dlrs said increased sales reflect initial shipments its fluoroscan imaging systems low radiation ray imaging devices recently were classified underwriters laboratories inc reuter 